FDA NDC Directory · JSON-LD · Markdown

Regadenoson

NDC 60505-6288 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameregadenoson
Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA207604
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsREGADENOSON (.08 mg/mL)
Marketing started20250403
Package count1

External sources

Source: openFDA. Public-domain (CC0).